[AFTER-CARE FOLLOWING CLINICAL CANCER THERAPY IN GYNECOLOGY].
D045930:Anabolic Agents; D001943:Breast Neoplasms; D005260:Female; D005833:Genital Neoplasms, Female; D006176:Gynecology; D006801:Humans; D007044:Hysterectomy; D007410:Intestinal Diseases; D008408:Mastectomy; D009369:Neoplasms / Q000532:radiotherapy*; D011182:Postoperative Care; D011832:Radiation Injuries; D013256:Steroids; D013739:Testosterone; D001745:Urinary Bladder Diseases; D001748:Urinary Bladder Neck Obstruction; D014594:Uterine Neoplasms; D014625:Vaginal Neoplasms; D014815:Vitamins
D045930:Anabolic Agents; D013256:Steroids; D014815:Vitamins; D013739:Testosterone
ANABOLIC STEROIDS; BLADDER DISEASES; BLADDER NECK OBSTRUCTION; BREAST NEOPLASMS; GYNECOLOGIC NEOPLASMS; HYSTERECTOMY; INTESTINAL DISEASES; MASTECTOMY; NEOPLASM RADIOTHERAPY; POSTOPERATIVE CARE; RADIATION INJURY; REVIEW; TESTOSTERONE; UTERINE NEOPLASMS; VAGINAL NEOPLASMS; VITAMINS